India’s pharma sector has emerged as a giant winner amid Trump’s tariff woes, because the US has exempted prescription drugs from reciprocal tariffs, recognizing the important position of India’s generic medicines in world healthcare. This determination comes amid US President Donald Trump’s announcement of 27 % tariffs on imports from about 60 nations, together with India, in retaliation to excessive import duties on American items. Business leaders are calling this exemption a big win for India, reinforcing its standing as a world pharmaceutical powerhouse.
The US administration’s determination to exempt prescription drugs from reciprocal tariffs emphasizes the important position of generic medicines in world healthcare, Sudarshan Jain, Secretary Normal of the Indian Pharmaceutical Alliance (IPA) advised information company PTI.
Jain highlighted that the exemption underscores the significance of inexpensive, life-saving generic medicines for public well being, financial stability, and nationwide safety. “India and the US share a powerful, rising bilateral commerce relationship, and prescription drugs stay a cornerstone of this partnership,” he stated. Jain additionally emphasised India’s pivotal position in world and US healthcare by guaranteeing a gentle provide of cost-effective medicines.
India’s pharmaceutical trade, he added, stays dedicated to furthering the shared priorities of each nations—strengthening the resilience of the medication provide chain and reinforcing nationwide safety by guaranteeing entry to inexpensive medicines for all.
IPA, a community of prime 23 Indian pharmaceutical firms together with Solar Pharma, Dr Reddy’s Laboratories, Lupin, Torrent, and Glenmark, represents the sector’s rising affect.
Bhavin Mukund Mehta, Vice-Chairman of Pharmexcil and Entire-Time Director of Kilitch Medicine, famous that the pharmaceutical sector is rising as a transparent beneficiary of this determination.
“India exports USD 8.7 billion value of prescription drugs to the US whereas importing simply USD 800 million. This sturdy commerce relationship creates a win-win state of affairs, driving important value financial savings on life-saving medicines,” Mehta acknowledged.
He additionally highlighted that Indian exporters stand to realize a aggressive benefit over their Asian counterparts, strengthening India’s world management in prescription drugs.
Sheetal Arora, Promoter and CEO of Mankind Pharma, described the exemption as a strategic recognition of the essential healthcare dependencies between the US and India. Arora identified that the US healthcare system closely is determined by India’s strong generic manufacturing and China’s energetic pharmaceutical ingredient (API) manufacturing. Any disruption in these provide chains would have rapid, extreme penalties for affected person care, he added.
Arora additionally emphasised that the exemption gives India with a possibility to reshape its pharmaceutical sector. By specializing in next-generation generics, accelerating biosimilar improvement, and boosting home API manufacturing, India may cut back geopolitical vulnerabilities and additional strengthen its place as the worldwide pharmacy. He talked about that initiatives just like the Manufacturing Linked Incentive (PLI) scheme, together with focused R&D incentives and regulatory harmonization, supply a framework to drive this transformation.
The pharmaceutical sector is India’s largest industrial export, valued at USD 12.72 billion in 2024. Indian pharmaceutical firms provide a good portion of medicine to the US, with 4 out of ten prescriptions crammed within the US in 2022 coming from Indian firms. The truth is, medicines from Indian firms saved the US healthcare system USD 219 billion in 2022 and a complete of USD 1.3 trillion from 2013 to 2022. Over the subsequent 5 years, generics from Indian firms are anticipated to generate a further USD 1.3 trillion in financial savings.
Specialists had beforehand warned that increased tariffs on pharmaceutical imports to the US may enhance manufacturing prices for Indian drug producers, making their merchandise much less aggressive. Smaller drug companies, working on skinny margins, may face monetary strain, doubtlessly resulting in consolidation or closure.
var _mfq = window._mfq || [];
_mfq.push([“setVariable”, “toi_titan”, window.location.href]);
!(function(f, b, e, v, n, t, s) {
function loadFBEvents(isFBCampaignActive) {
if (!isFBCampaignActive) {
return;
}
(function(f, b, e, v, n, t, s) {
if (f.fbq) return;
n = f.fbq = function() {
n.callMethod ? n.callMethod(…arguments) : n.queue.push(arguments);
};
if (!f._fbq) f._fbq = n;
n.push = n;
n.loaded = !0;
n.version = ‘2.0’;
n.queue = [];
t = b.createElement(e);
t.async = !0;
t.defer = !0;
t.src = v;
s = b.getElementsByTagName(e)[0];
s.parentNode.insertBefore(t, s);
})(f, b, e, ‘https://connect.facebook.net/en_US/fbevents.js’, n, t, s);
fbq(‘init’, ‘593671331875494’);
fbq(‘track’, ‘PageView’);
};
function loadGtagEvents(isGoogleCampaignActive) {
if (!isGoogleCampaignActive) {
return;
}
var id = document.getElementById(‘toi-plus-google-campaign’);
if (id) {
return;
}
(function(f, b, e, v, n, t, s) {
t = b.createElement(e);
t.async = !0;
t.defer = !0;
t.src = v;
t.id = ‘toi-plus-google-campaign’;
s = b.getElementsByTagName(e)[0];
s.parentNode.insertBefore(t, s);
})(f, b, e, ‘https://www.googletagmanager.com/gtag/js?id=AW-877820074’, n, t, s);
};
function loadSurvicateJs(allowedSurvicateSections = []){
const section = window.location.pathname.split(‘/’)[1]
const isHomePageAllowed = window.location.pathname === ‘/’ && allowedSurvicateSections.includes(‘homepage’)
if(allowedSurvicateSections.includes(section) || isHomePageAllowed){
(function(w) {
function setAttributes() {
var prime_user_status = window.isPrime ? ‘paid’ : ‘free’ ;
w._sva.setVisitorTraits({
toi_user_subscription_status : prime_user_status
});
}
if (w._sva && w._sva.setVisitorTraits) {
setAttributes();
} else {
w.addEventListener(“SurvicateReady”, setAttributes);
}
var s = document.createElement(‘script’);
s.src=”https://survey.survicate.com/workspaces/0be6ae9845d14a7c8ff08a7a00bd9b21/web_surveys.js”;
s.async = true;
var e = document.getElementsByTagName(‘script’)[0];
e.parentNode.insertBefore(s, e);
})(window);
}
}
window.TimesApps = window.TimesApps || {};
var TimesApps = window.TimesApps;
TimesApps.toiPlusEvents = function(config) {
var isConfigAvailable = “toiplus_site_settings” in f && “isFBCampaignActive” in f.toiplus_site_settings && “isGoogleCampaignActive” in f.toiplus_site_settings;
var isPrimeUser = window.isPrime;
var isPrimeUserLayout = window.isPrimeUserLayout;
if (isConfigAvailable && !isPrimeUser) {
loadGtagEvents(f.toiplus_site_settings.isGoogleCampaignActive);
loadFBEvents(f.toiplus_site_settings.isFBCampaignActive);
loadSurvicateJs(f.toiplus_site_settings.allowedSurvicateSections);
} else {
var JarvisUrl=”https://jarvis.indiatimes.com/v1/feeds/toi_plus/site_settings/643526e21443833f0c454615?db_env=published”;
window.getFromClient(JarvisUrl, function(config){
if (config) {
const allowedSectionSuricate = (isPrimeUserLayout) ? config?.allowedSurvicatePrimeSections : config?.allowedSurvicateSections
loadGtagEvents(config?.isGoogleCampaignActive);
loadFBEvents(config?.isFBCampaignActive);
loadSurvicateJs(allowedSectionSuricate);
}
})
}
};
})(
window,
document,
‘script’,
);
